导航
| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | 6.05% | 388/1050 |
| 近一周 | -1.06% | 472/1104 |
| 近一月 | -1.57% | 300/1103 |
| 近一季 | -5.57% | 498/1092 |
| 近半年 | 2.74% | 377/1070 |
| 近一年 | 10.21% | 364/1018 |
| 近两年 | 55.44% | 476/926 |
| 近三年 | 35.06% | 366/834 |
| 成立以来 | 144.18% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2026 | - - |
-1.74% 616/1070 |
18.68% 398/1101 |
- - |
- - |
| 2025 | 21.89% 631/1065 |
0.12% 792/1014 |
2.17% 491/1038 |
16.84% 700/1050 |
1.97% 312/1065 |
| 2024 | 10.45% 277/1011 |
1.83% 218/960 |
-1.34% 395/983 |
12.55% 414/991 |
-2.32% 476/1011 |
| 2023 | -9.69% 320/952 |
2.37% 486/880 |
-4.08% 456/895 |
-3.25% 218/915 |
-4.93% 492/952 |
| 2022 | -19.59% 310/867 |
-10.31% 115/773 |
3.60% 601/806 |
-10.57% 282/845 |
-3.24% 589/867 |
| 2021 | 4.55% 310/740 |
2.08% 88/580 |
9.33% 378/659 |
-4.07% 314/704 |
-2.35% 526/740 |
| 2020 | 45.59% 266/554 |
-5.86% 313/419 |
19.49% 294/466 |
16.65% 116/517 |
10.96% 336/554 |
| 2019 | 36.49% 247/410 |
24.44% 746/1146 |
-0.48% 409/1228 |
3.96% 222/390 |
6.02% 309/410 |
| 2018 | -19.81% 73/349 |
- - |
-5.26% 193/990 |
-2.00% 305/1000 |
-12.30% 630/1080 |
| 2017 | 35.55% 20/285 |
- - |
- - |
- - |
- - |
| 2016 | - - |
- - |
- - |
- - |
- - |
| 2015 | - - |
- - |
- - |
- - |
- - |
| 2014 | - - |
- - |
- - |
- - |
- - |
| 2013 | - - |
- - |
- - |
- - |
- - |
| 2012 | - - |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 招商前沿医疗保健股票A | 0.8665 | 61.36% |
| 招商前沿医疗保健股票C | 0.8313 | 61.04% |
| 招商医药健康产业股票 | 2.7000 | 53.78% |
| 前海开源公共卫生股票A | 0.4844 | 46.12% |
| 广发医药精选股票A | 1.3562 | 44.63% |
| 嘉实医疗保健股票 | 2.6570 | 42.34% |
| 前海开源公共卫生股票C | 0.4741 | 42.24% |
| 广发医药精选股票C | 1.3346 | 40.86% |
| 交银医药创新股票A | 2.9498 | 37.46% |
| 交银医药创新股票C | 3.1324 | 37.26% |
| 景顺长城量化新动力股票 VS. 东吴新产业精选股票A(580008) |